A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).

被引：0
|
作者：
Hendifar, Andrew Eugene
Kim, Sungjin
Tighiouart, Mourad
Hautamaki, Emily
Kim, Haesoo
Ng, Camille
Liu, Jar-Yee
Scher, Kevin S.
Klempner, Samuel J.
Placencio-Hickok, Veronica
Gresham, Gillian
Gong, Jun
机构：
[1] Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, West Hollywood, CA USA
[4] Tower Hematol Oncol Med Grp, Beverly Hills, CA USA
[5] Angeles Clin & Res Inst, Los Angeles, CA USA
[6] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4634
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
    Kawakami, Takeshi
    Todaka, Akiko
    Oshima, Kotoe
    Fushiki, Kunihiro
    Hamauchi, Satoshi
    Tsushima, Takahiro
    Yokota, Tomoya
    Onozawa, Yusuke
    Yasui, Hirofumi
    Yamazaki, Kentaro
    BMC CANCER, 2023, 23 (01)
  • [22] Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer
    Kuehr, T
    Ruff, P
    Rapoport, BL
    Falk, S
    Daniel, F
    Jacobs, C
    Davidson, N
    Thaler, J
    Boussard, B
    Carmichael, J
    BMC CANCER, 2004, 4 (1)
  • [23] Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
    Jun Gong
    Shant Thomassian
    Sungjin Kim
    Gillian Gresham
    Natalie Moshayedi
    Jason Y. Ye
    Julianne C. Yang
    Jonathan P. Jacobs
    Simon Lo
    Nick Nissen
    Srinivas Gaddam
    Mourad Tighiouart
    Arsen Osipov
    Andrew Hendifar
    Scientific Reports, 12
  • [24] CARDIOTOXICITY OF 5-FLUOROURACIL IN COMBINATION WITH FOLINIC ACID IN PATIENTS WITH GASTROINTESTINAL CANCER
    SCHOBER, C
    PAPAGEORGIOU, E
    HARSTRICK, A
    BOKEMEYER, C
    MUGGE, A
    STAHL, M
    WILKE, H
    POLIWODA, H
    HIDDEMANN, W
    KOHNEWOMPNER, CH
    WEISS, J
    PREISS, J
    SCHMOLL, HJ
    CANCER, 1993, 72 (07) : 2242 - 2247
  • [25] Nanoliposomal irinotecan plus fluorouracil and folinic acid in irinotecan-pretreated vs. -naive pancreatic cancer patients: A retrospective cohort study
    Schoenlein, M.
    Stein, A.
    Tintelnot, J.
    Nilsson, S.
    Reichelt, R.
    Borchardt, J.
    Schnell, R.
    Goekkurt, E.
    Bokemeyer, C.
    Sinn, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 224 - 225
  • [26] A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer
    Kodama, Tomoko
    Imajima, Takashi
    Shimokawa, Mototsugu
    Otsuka, Taiga
    Kawahira, Masahiro
    Nakazawa, Junichi
    Hori, Takeshi
    Shibuki, Taro
    Arima, Shiho
    Ido, Akio
    Miwa, Keisuke
    Okabe, Yoshinobu
    Koga, Futa
    Ueda, Yujiro
    Kubotsu, Yoshihito
    Shimokawa, Hozumi
    Takeshita, Shigeyuki
    Nishikawa, Kazuo
    Komori, Azusa
    Otsu, Satoshi
    Hosokawa, Ayumu
    Sakai, Tatsunori
    Sakai, Kenji
    Oda, Hisanobu
    Kawahira, Machiko
    Arita, Shuji
    Honda, Takuya
    Taguchi, Hiroki
    Tsuneyoshi, Kengo
    Kawaguchi, Yasunori
    Fujita, Toshihiro
    Sakae, Takahiro
    Shirakawa, Tsuyoshi
    Mizuta, Toshihiko
    Mitsugi, Kenji
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
    Gubanski, Michael
    Johnsson, Anders
    Fernebro, Eva
    Kadar, Lianna
    Karlberg, Ingegerd
    Flygare, Petra
    Berglund, Ake
    Glimelius, Bengt
    Lind, Pehr A.
    GASTRIC CANCER, 2010, 13 (03) : 155 - 161
  • [28] Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
    Michael Gubanski
    Anders Johnsson
    Eva Fernebro
    Lianna Kadar
    Ingegerd Karlberg
    Petra Flygare
    Åke Berglund
    Bengt Glimelius
    Pehr A. Lind
    Gastric Cancer, 2010, 13 : 155 - 161
  • [29] Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy: A real-world experience
    Yu, Hung-Yuan
    Lee, Chun-Yang
    Lin, Le-Gin
    Chao, Yee
    Li, Chung-Pin
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (01) : 42 - 50
  • [30] TREATMENT OF ADVANCED COLORECTAL-CANCER WITH FOLINIC ACID AND 5-FLUOROURACIL IN COMBINATION WITH CISPLATINUM
    SAGASTER, P
    ESSL, R
    TEICH, G
    FRITZ, E
    WASILEWSKI, M
    UMEK, H
    DUNSER, E
    MASCHER, H
    MICKSCHE, M
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1250 - 1254
12345